The global connected drug delivery devices market was valued at USD 1,081.78 Million in 2024 and is expected to reach USD 8,142.87 Million by 2033, growing at a CAGR of 23.13% from 2025 to 2033. Growth is driven by technological advancements, increasing chronic disease prevalence, and rising adoption of connected devices. North America leads with a market share of over 41.2% in 2024. The...